UK Set to Test World's First Vaccine For Vomiting Bug Norovirus
UK Set to Test World's First Vaccine For Vomiting Bug Norovirus
The Facts
Pharma firm Moderna is set to test the world's first vaccine against norovirus, a highly contagious vomiting bug. The virus reportedly causes around 12K hospitalities in the UK alone — and 685M cases of gastroenteritis globally — each year, especially in winters.Pharmaceutical firm Moderna is set to test the world's first vaccine against norovirus, a highly contagious stomach bug. The virus reportedly causes around 12K hospitalities in the UK alone — and 685M cases of gastroenteritis globally — each year, especially during winters.
Norovirus, or the winter vomiting bug, spreads via contact with infected persons or through contaminated surfaces or food and water. Its symptoms are nausea, projectile vomiting, diarrhea, high temperature, severe abdominal pain, and aching limbs. It affects people of all ages.
The Spin
A norovirus vaccine will mark a crucial breakthrough. Norovirus's ability to spread rapidly in close quarters makes it a public health concern. With no current treatment and prevention reliant on hygiene, a vaccine would be a game-changer, potentially reducing the burden of outbreaks and preventing severe cases.
The increase in norovirus cases is a natural consequence of returning to normal social interactions after the covid-era cloistering. The human immune system needs exposure to common viruses to maintain strength. While a vaccine is always welcome, overreacting to a situation could lead to unnecessary panic and disruption of daily life.
